Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy ResearchNOW IN
    Article

    HPLC-DAD-ESI-MS/MS Characterization of Bioactive Secondary Metabolites from Strelitzia nicolai Leaf Extracts and Their Antioxidant and Anticancer Activities In vitro

    Mosad Ghareeb1★, Amal Saad1, Wafaa Ahmed1,2, Laila Refahy1, Sami Nasr3★ Corresponding author

    1. 1Departments of Medicinal Chemistry, Theodor Bilharz Research Institute, Giza, EGYPT.
    2. 2Department of Chemistry, College of Science and Arts, Sajir, Shaqra University, Shaqra, SAUDI ARABIA.
    3. 3Departments of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, EGYPT.

    CORRESPONDENCE

    Mosad Ghareeb

    Departments of Medicinal Chemistry, Theodor Bilharz Research Institute, Giza, EGYPT.

    m.ghareeb@tbri.gov.eg

    Volume 10, Issue 4 · pp. 368–378 · PUBLISHED · DOI: 10.4103/pr.pr_89_18

    View on Pharmacogn. Res. original site ↗

    ABSTRACT

    Background: Strelitzia nicolai Regel and Körn (Strelitziaceae) is native to Southern Africa whose phytochemistry and pharmacology were slightly investigated. Materials and Methods:In the current work, different solvent extracts of S. nicolaiwere screened for their chemical profiles through high‑performance liquid chromatography coupled with diode array detection and electrospray ionization mass spectrometry (HPLC‑DAD‑ESI‑MS/MS) analyses. Furthermore, their in vitro antioxidant, cytotoxic, and anticancer activities were evaluated using 2,2’‑diphenyl‑1‑picrylhydrazyl radical (DPPH), 2,2’‑azino‑bis (3‑ethylbenzothiazoline‑6‑sulphonic acid) (ABTS) & ferric reducing antioxidant power (FRAP) and crystal violet staining (CVS) colorimetric assays, respectively. Results: HPLC‑DAD‑ESI‑MS/MS analyses led to the identification of nineteen and eleven phenolic compounds from the ethyl acetate and n‑butanol extracts, respectively including flavonoids (e.g., quercetin 3‑(2 G‑rhamnosylrutinoside, quercetin, quercetin‑3‑O‑glucoside, kaempferol‑3,7‑O‑dirhamnoside, isorhamnetin‑3‑O‑rutinoside and kaempferol‑3‑O‑glucoside), phenolic acids derivatives (e.g., chlorogenic acid glycoside, protocatechuic acid‑O‑glucoside and caftaric acid ), chalcones (e.g., xanthoangelol), and phenylethanoids (e.g., ligstroside glucoside). Moreover, in the DPPH assay the IC50 value of the most active ethyl acetate extract was 20.49 μg/mL, relative to 2.92 μg/mL of ascorbic acid. ABTS and FRAP results reinforced the results of DPPH assay. According to the National Cancer Institute criteria, the tested extracts showed weak to moderate cytotoxic activities with IC50 values ranged from 65.23 to 451.29 μg/ mL. Furthermore, the EtOAc and n‑BuOH extracts showed a noticeable anticancer activity with CVS spectroscopic readings for liver hepatocellular carcinoma growth 0.806 and 0.684 at a concentration (125 μg/mL), as well as 0.730 and 0.618 at concentration (500 μg/mL), respectively against control at 1.022. Conclusion:The obtained results reveal the high efficacy of the phenolic‑rich extracts from S. nicolai as naturally occurring antioxidant and anti‑tumor agents.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Ghareeb, M., Saad, A., Ahmed, W., Refahy, L., & Nasr, S. (). HPLC-DAD-ESI-MS/MS Characterization of Bioactive Secondary Metabolites from Strelitzia nicolai Leaf Extracts and Their Antioxidant and Anticancer Activities In vitro. Pharmacognosy Research, 10(4), 368–378. https://doi.org/10.4103/pr.pr_89_18